FLG client QuantaLife, Inc., announced its acquisition for $162 million in cash plus contingent payments by Bio-Rad Laboratories, Inc.. Company press release. FLG partner: James Pardee.
Recent News
Saluda Medical Announces Closing of $100 Million Financing
MINNEAPOLIS, MN — January 10, 2025 (PR Newswire) Saluda Medical, Inc., a commercial-stage medical device company focused on development treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. FLG Managing Partner Laureen DeBuono assisted as Board of Directors…Read More
Read More
Testimonials
“Taking over management of Adaptive Path, I needed an experienced partner who advocated for the health of the business and could be a counselor on big decisions. From turnaround of the business through to our acquisition by Capital One, Skip Smith from FLG Partners was that and much more. His work began with focusing us on building back a healthy business step-by-step, improving the accounting and analysis to make sure we made every project and every month, a profitable one. His role matured to shaping our recapitalization and mentoring me and other top managers in the organization as we ran and grew the business. Skip also made key introductions that supported our acquisition process. Throughout it all, I trusted Skip for his straight read on situations, tough advice that I needed to hear, but also for his love of our business and his passion to see it succeed with the leadership of myself and my team. Skip was central to our success.”
Brandon Schauer, Head of Emerging Design Practices, Capital OneRead More